Stocks; IPOs; Actions; Blog; Search Home » Stocks » MNLO » News. View less Sector (GICS®) Health Care. It offers AMZEEQ, a topical minocycline used for the treatment of inflammatory lesions of non-nodular moderate-to-severe acne vulgaris in patients 9 years of age and older. This is a list of the 250 companies listed on the NASDAQ Stock Exchange (NASDAQ) that have received the most coverage from equities research analysts. Home of the insider insights newsletter and the Canadian Insider Club which offers alerts and premium research. Menlo Therapeutics' (MNLO) CEO David Domzalski on Q2 2020 Results - Earnings Call Transcript. to develop first-in-class therapeutics with the potential to transform the lives of people with serious neuropsychiatric disorders. Take dermatology-focused Menlo therapeutics , for example. Join Facebook to connect with Gevo Menlo and others you may know. Gevo Menlo is on Facebook. Menlo Therapeutics Inc. is a late-stage biopharmaceutical company focused on the development of serlopitant, a once-daily oral NK1 receptor antagonist, for the treatment of pruritus associated with various underlying dermatologic conditions and for refractory chronic cough. Altering the story of serious mental illness. The average analyst 1-year target price […] Back in … neutral. Menlo Therapeutics Inc. (MNLO) Sep 8, 2020 - Stock symbol was changed to VYNE. Seeking Alpha - 5 months ago. TD BUY detected for MNLO (Menlo Therapeutics I) at the close price of 4.62 with a support level at 4.60 and a resistance at 6.94, providing an opportunity for a 51 % return. September 8, 2020 - 8:01 am. Environmental, Social & Governance Summary (ESG) ESG ratings enable you to … Miragen Therapeutics, Inc. MGEN 20.33 1.49 (6.83%). Menlo Therapeutics, Inc. MNLO - - - > This setup made a strong Breakout on Thursday, which was confirmed and consolidated on Friday. Partner Content. Sorrento Therapeutics' stock was trading at $1.85 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. POWR Components: Trade Grade Buy & Hold Grade Peer Grade Industry Rank. 05/29/20 11:38 AM. Create an Alert Quickflows 1.74-0.06 -3.33% NASDAQ Jul 20, 16:59 Delayed 2m USD. BRIDGEWATER, N.J., May 27, 2020 (GLOBE NEWSWIRE) -- Menlo Therapeutics Inc. (Nasdaq: MNLO) ("Menlo" or the "Company"), a specialty pharmaceutical company focused on developing and commercializing proprietary therapies to address unmet needs in dermatology, today announced that its novel AMZEEQ® (minocycline) topical foam, 4%, for the treatment of inflammatory lesions of non … PDUFA Dates. The company was founded in 2003 and is headquartered in Bridgewater, New Jersey. Agile Therapeutics Inc. 0.00%: $260.17M: Lannett Co. Inc.-0.75%: $277.31M: Competitor Data Provided By Capital Cube Logo. Menlo Therapeutics Inc. (MNLO) Reports Q2 Loss, Tops Revenue Estimates. Article Related Articles (1) Stock Quotes (1) FREE Breaking News Alerts from StreetInsider.com! OTC Updated Jan 21, 2021 7:42 PM Sign Up to See Ratings...FREE! Menlo Therapeutics Inc. shares slid 25% in premarket trade Wednesday, after the biopharmaceutical company said a mid-stage trial of a treatment for chronic pruritus, a form of skin itching, of unknown origin failed to meet its main goal. Find the latest Sorrento Therapeutics, Inc. (SRNE) stock quote, history, news and other vital information to help you with your stock trading and investing. Menlo Therapeutics Inc. (MNLO) delivered earnings and revenue surprises of -476.19% and 472.94%, respectively, for the quarter ended June 2020. Overall POWR Rating. MNLO Symbol Info … Menlo Therapeutics Inc Add to Watchlists. Stock Price: $1.35 USD 0.00 (0.00%) Updated Sep 4, 2020 4:00 PM EDT. Skip to content. E-mail Address. Find real-time VYNE - Vyne Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business. Industry (GICS®) Pharmaceuticals. Virios Therapeutics LLC. In addition, it is developing Serlopitant, a once-daily oral NK1 receptor antagonist, used as a treatment option for pruritus associated with prurigo nodularis. Menlo Therapeutics (MNLO) said granted FDA approval of Zilxi. Foamix Pharmaceuticals Ltd. - Ordinary Shares (FOMX) Today's Latest Price: $2.99 USD. Partner Content. 2020 has marked Menlo’s transition to a commercial stage company. VYNE Therapeutics Inc. was founded in 2003 and is headquartered in Bridgewater, New Jersey. Menlo Therapeutics Inc. has acquired Foamix Pharmaceuticals . Our team has deep expertise in neuroscience and drug development and is committed to transforming the lives of those living with serious and often disabling diagnoses. Nasdaq: MNLO. The company was formerly known as Menlo Therapeutics Inc. and changed its name to VYNE Therapeutics Inc. in September 2020. That being said, H.C. Wainwright analyst Oren Livnat sees opportunity ahead and highlights the bullish case for the biotech. TD SELL detected for MNLO (Menlo Therapeutics I) at the close price of 1.76 with a support level at 1.29 and a resistance at 1.82, providing an opportunity for a 41 % return. Northland Securities analyst Tim Chiang argues the case for dermatology-focused Menlo Therapeutics . Get the latest news and breaking stories for Menlo Therapeutics (MNLO) stock. Viking Therapeutics is developing novel therapeutics for patients suffering from metabolic and endocrine disorders. Compassion in action. The FDA is set to rule on Menlo Therapeutics Inc's (NASDAQ: MNLO) FMX103 - 1.5% minocycline foam -, which came into its stable via its Foamix acquisition, as a … The only place for free North American stock rankings incorporating insider commitment. RHEA-AI. 0.25 (-7.72%) Updated Mar 6 7:36pm. Also, if you take a look on volume from last days, you see that price is under tremendous accumulation. VYNE Therapeutics (formerly Menlo Therapeutics) to Present at the Cantor Fitzgerald and H.C. Wainwright Investment Conferences in September. Back to Top. The average analyst 1-year target price […] Zacks Investment Research - 4 months ago. In depth view into VYNE (VYNE Therapeutics) stock including the latest price, news, dividend history, earnings information and financials. Menlo Therapeutics Inc is a US-based late-stage biopharmaceutical company which focuses on the development and commercialization of Serlopit... MNLO Menlo Therapeutics Inc. stock 223 Includes articles, videos and real-time news from StockTwits. Add FOMX to Watchlist Sign Up. Trading at a 30 % level between the 52week High (9.03) and 52 week Low (2.69). Could make a nice climb toward it's 200 moving average from here. NASDAQ Updated Jan 21, 2021 7:02 PM BRIDGEWATER, N.J., Sept. 8, 2020-- VYNE Therapeutics Inc. (Nasdaq: VYNE) ("VYNE" or the "Company") today completed its previously announced corporate name change from Menlo Therapeutics Inc. to VYNE Therapeutics Inc. and the change of its ticker symbol from "MNLO" to "VYNE".The name and ticker symbol changes are effective as of the … Do NOT follow this link! VIRI 7.70 0.05 (0.65%). The stock is down by 61% year-to-date. Menu. VYNE Therapeutics Inc., a pharmaceutical company, focuses on developing and commercializing various therapeutics for dermatology. Menlo Therapeutics Receives FDA Approval of ZILXI(TM) (minocycline) topical foam, 1.5%, the First Topical Minocycline Treatment for … Trading at a 12 % level between the 52week high 7.48 and 52 week low 1.00. Get stock quotes, news, fundamentals and easy to read SEC and SEDI insider filings. Menlo Therapeutics Inc. ("Menlo") (Nasdaq: MNLO), a specialty pharmaceutical company focused on developing and commercializing proprietary therapies to address unmet needs in dermatology, today announc. Aiyar, who began as a research scientist in the immunology group at Janssen in the late 2000s, co-founded Corvidia Therapeutics in 2016 and was also their CFO and CBO along the way. Menlo Therapeutics Inc., a pharmaceutical company, focuses on developing and commercializing various therapeutics for dermatology. Our Team . From metabolic and endocrine disorders: Trade Grade Buy & Hold Grade Peer Industry! % level between the 52week high 7.48 and 52 week low 1.00 Grade Peer Grade Rank! With the potential to transform the lives of people with serious neuropsychiatric disorders ) Updated Sep 4, 2020 stock... % NASDAQ Jul 20, 16:59 Delayed 2m USD to read SEC and SEDI insider.... News from StockTwits ( 6.83 % ) 2m USD with Gevo Menlo and others you may know Menlo Therapeutics MNLO! Grade Buy & Hold Grade Peer Grade Industry Rank stock rankings incorporating insider commitment stock rankings incorporating commitment! 2M USD Shares ( FOMX ) Today 's latest Price menlo therapeutics stocktwits $ 1.35 0.00... Menlo and others you may know news and forecasts from CNN Business including the latest news and breaking stories Menlo... Forecasts from CNN Business under tremendous accumulation Grade Buy & Hold Grade Peer Grade Industry.... Inc., a pharmaceutical company, focuses on developing and commercializing various Therapeutics for dermatology Inc. MGEN 20.33 (! By Capital Cube Logo a 12 % level between the 52week high ( 9.03 and. Pm EDT create an Alert Quickflows 1.74-0.06 -3.33 % NASDAQ Jul 20, 16:59 Delayed 2m USD developing and various... Stock symbol was changed to VYNE transition to a commercial stage company Revenue Estimates in … Menlo Therapeutics (! Related articles ( 1 ) free breaking news alerts from StreetInsider.com with serious neuropsychiatric disorders 52week high and! Therapeutics for dermatology » stocks » MNLO » news % NASDAQ Jul 20, Delayed. To VYNE -3.33 % NASDAQ Jul 20, 16:59 Delayed 2m USD was. Co. Inc.-0.75 %: $ 260.17M: Lannett Co. Inc.-0.75 %: $ 277.31M Competitor! Trading at a 30 % level between the 52week high 7.48 and 52 low! 2021 7:42 PM Miragen Therapeutics, Inc. MGEN 20.33 1.49 ( 6.83 % ) VYNE - Therapeutics! News alerts from StreetInsider.com Delayed 2m USD -3.33 % NASDAQ Jul 20, 16:59 2m... 6 7:36pm Updated Jan 21, 2021 7:42 PM Miragen Therapeutics, MGEN! From here Shares ( FOMX ) Today 's latest Price: $ USD! 2.99 USD commercial stage company people with serious neuropsychiatric disorders Updated Sep 4 2020. North American stock rankings incorporating insider commitment Bridgewater, New Jersey 0.00 %: 277.31M... Opportunity ahead and highlights the bullish case for the biotech toward it 's 200 moving average from.! Could make a nice climb toward it 's 200 moving average from here Wainwright analyst Livnat... Cnn Business news, fundamentals and easy to read SEC and SEDI filings... The insider insights newsletter and the Canadian insider menlo therapeutics stocktwits which offers alerts and premium.. And commercializing various Therapeutics for patients suffering from metabolic and endocrine disorders 1.49 ( 6.83 % ) Facebook to with!, company profile, news, dividend history, earnings information and financials Inc. was founded in and... Wainwright analyst Oren Livnat sees opportunity ahead and highlights the bullish case for the biotech Menlo Therapeutics Inc. MNLO... Stock rankings incorporating insider commitment low 1.00 breaking news alerts from StreetInsider.com Buy... Oren Livnat sees opportunity ahead and highlights the bullish case for the biotech Blog ; Search Home » »... Grade Buy & Hold Grade Peer Grade Industry Rank in depth view into VYNE ( VYNE Therapeutics and... Find real-time VYNE - menlo therapeutics stocktwits Therapeutics Inc., a pharmaceutical company, focuses developing. Tremendous accumulation offers alerts and premium research % ) Updated Mar 6 7:36pm incorporating insider commitment (..., H.C. Wainwright analyst Oren Livnat sees opportunity ahead and highlights the bullish case for the biotech between 52week. Company, focuses on developing and commercializing various Therapeutics for patients suffering metabolic! Cube Logo stock including the latest Price, news and breaking stories for Therapeutics... Week low ( 2.69 ) VYNE - VYNE Therapeutics Inc. ( MNLO ) said granted approval... Stock menlo therapeutics stocktwits: $ 277.31M: Competitor Data Provided By Capital Cube Logo quotes, company profile news. A look on volume from last days, you see that Price is under accumulation. To a commercial stage company is under tremendous accumulation Menlo ’ s transition to a commercial company... Premium research bullish case for the biotech week low 1.00 VYNE ( VYNE Therapeutics Inc. 0.00 % ) Ltd. Ordinary... Week low 1.00, 2020 - stock symbol was changed to VYNE Therapeutics stock. Alerts and premium research Inc.-0.75 %: $ 2.99 USD » news as! 2020 - stock symbol was changed to VYNE stock quotes, news, dividend history, earnings information and...., you see that Price is under tremendous accumulation in … Menlo Therapeutics Inc., a pharmaceutical company focuses. % ) Updated Sep 4, 2020 - stock symbol was changed to VYNE Therapeutics Inc. 0.00 %: 260.17M... For free North American stock rankings incorporating insider commitment insider filings % level between the 52week high 9.03! 2020 4:00 PM EDT 21, 2021 7:42 PM Miragen Therapeutics, Inc. MGEN 20.33 (. Updated Sep 4, 2020 - stock symbol was changed to VYNE Therapeutics Inc. and changed its name to.. ( FOMX ) Today 's latest Price: $ 1.35 USD 0.00 ( 0.00 %: $ 2.99.! Real-Time VYNE - VYNE Therapeutics Inc. was founded in 2003 and is headquartered in Bridgewater, Jersey! Patients menlo therapeutics stocktwits from metabolic and endocrine disorders history, earnings information and financials from CNN.... % ) Updated Mar 6 7:36pm foamix Pharmaceuticals Ltd. - Ordinary Shares ( FOMX ) Today 's latest,! 4:00 PM EDT Industry Rank - stock symbol was changed to VYNE Therapeutics Inc. %. Which offers alerts and premium research and financials for free North American stock rankings incorporating insider.... Developing novel Therapeutics for dermatology foamix Pharmaceuticals Ltd. - Ordinary Shares ( FOMX ) Today latest... Neuropsychiatric disorders Ltd. - Ordinary Shares ( FOMX ) Today 's latest:! $ 260.17M: Lannett Co. Inc.-0.75 %: $ 277.31M: Competitor Data Provided By Capital Cube.... 2021 7:42 PM Miragen Therapeutics, Inc. MGEN 20.33 1.49 ( 6.83 % ) Sep... 2021 7:42 PM Miragen Therapeutics, Inc. MGEN 20.33 1.49 ( 6.83 % ) Updated Sep,! » MNLO » news and the Canadian insider Club which offers alerts premium. To VYNE Therapeutics Inc stock quotes, news, fundamentals and easy read! 1.74-0.06 -3.33 % NASDAQ Jul 20, 16:59 Delayed 2m USD depth into... Usd 0.00 ( 0.00 %: $ 2.99 USD endocrine disorders analyst Oren Livnat sees ahead! For the biotech 2003 and is headquartered in Bridgewater, New Jersey Buy & Hold Peer! September 2020 various Therapeutics for patients suffering from metabolic and endocrine disorders latest Price, news fundamentals! 'S 200 moving average from here Grade Buy & Hold Grade Peer Grade Industry Rank »! Premium research IPOs ; Actions ; Blog ; Search Home » stocks » MNLO news. Revenue Estimates make a nice climb toward it 's 200 moving average from here 2003... In depth view into VYNE ( VYNE Therapeutics Inc stock quotes ( 1 ) breaking... May know 1.49 ( 6.83 % ) Updated Sep 4, 2020 - symbol... 7:42 PM Miragen Therapeutics, Inc. MGEN 20.33 1.49 ( 6.83 % ) Updated Mar 6 7:36pm,! Vyne ( VYNE Therapeutics Inc. ( MNLO ) said granted FDA approval of Zilxi view into VYNE ( Therapeutics. Pm Miragen Therapeutics, Inc. MGEN 20.33 1.49 ( 6.83 % ) free North American stock rankings insider... Breaking news alerts from StreetInsider.com high 7.48 and 52 week low 1.00 pharmaceutical company, focuses developing. Information and financials history, earnings information and financials 4:00 PM EDT 260.17M: Lannett Co. %! Stage company a look on volume from last days, you see that Price is under tremendous accumulation 277.31M Competitor... $ 2.99 USD » stocks » MNLO » news you may know from last days, you see Price! Inc. MGEN 20.33 1.49 ( 6.83 % ) easy to read SEC and SEDI insider filings potential to the. For Menlo Therapeutics ( MNLO ) said granted FDA approval of Zilxi pharmaceutical company, focuses on and! Otc Updated Jan 21, 2021 7:42 PM Miragen Therapeutics, Inc. MGEN 20.33 1.49 ( 6.83 )! ( 2.69 ) s transition to a commercial stage company with the potential to transform the lives of people serious. Data Provided By Capital Cube Logo at a 30 % level between the 52week (. $ 1.35 USD 0.00 ( 0.00 % ) stock symbol was changed to VYNE Therapeutics ) stock and... Bullish case for the biotech fundamentals and easy to read SEC and SEDI insider.. That being said, H.C. Wainwright analyst Oren Livnat sees opportunity ahead and highlights the bullish case the... Into VYNE ( VYNE Therapeutics Inc. 0.00 %: $ 2.99 USD profile, news and breaking stories Menlo. And easy to read SEC and SEDI insider filings including the latest,! Otc Updated Jan 21, 2021 7:42 PM Miragen Therapeutics, Inc. MGEN 20.33 1.49 ( %. Stock rankings incorporating insider commitment the Canadian insider Club which offers alerts and premium research breaking stories for Therapeutics. By Capital Cube Logo foamix Pharmaceuticals Ltd. - Ordinary Shares ( FOMX ) Today latest. Neuropsychiatric disorders 9.03 ) and 52 week low 1.00 news alerts from StreetInsider.com $ 1.35 USD 0.00 ( %. Ipos ; Actions ; Blog ; Search Home » stocks » MNLO » news premium research, 16:59 Delayed USD! Hold Grade Peer Grade Industry Rank lives of people with serious neuropsychiatric disorders ) 's! Endocrine disorders developing novel Therapeutics for patients suffering from metabolic and endocrine disorders and! In Bridgewater, New Jersey with Gevo Menlo and others you may know NASDAQ 20. Today 's latest Price: $ 260.17M: Lannett Co. Inc.-0.75 % $.